OpenURL Connection Search

Select item for more details and to access through your institution.

A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.
Published in:
Investigational New Drugs, 2024, v. 42, n. 3, p. 241, doi. 10.1007/s10637-024-01428-0
By:
- Chénard-Poirier, Maxime;
- Hansen, Aaron R.;
- Gutierrez, Martin E.;
- Rasco, Drew;
- Xing, Yan;
- Chen, Lin-Chi;
- Zhou, Heng;
- Webber, Andrea L.;
- Freshwater, Tomoko;
- Sharma, Manish R.
Publication type:
Article
Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer.
Published in:
Drugs, 2019, v. 79, n. 1, p. 1, doi. 10.1007/s40265-018-1032-1
By:
- Chénard-Poirier, Maxime;
- Smyth, Elizabeth C.
Publication type:
Article
Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.
Published in:
2018
By:
- Sundar, Raghav;
- Miranda, Susana;
- Rodrigues, Daniel Nava;
- Chénard-Poirier, Maxime;
- Dolling, David;
- Clarke, Matthew;
- Figueiredo, Ines;
- Bertan, Claudia;
- Yuan, Wei;
- Ferreira, Ana;
- Chistova, Rossitza;
- Boysen, Gunther;
- Perez, Desamparados Roda;
- Tunariu, Nina;
- Mateo, Joaquin;
- Wotherspoon, Andrew;
- Chau, Ian;
- Cunningham, David;
- Valeri, Nicola;
- Carreira, Suzanne
Publication type:
journal article
Effects of Five Filamentous Fungi Used in Food Processes on In Vitro and In Vivo Gut Inflammation.
Published in:
Journal of Fungi, 2022, v. 8, n. 9, p. N.PAG, doi. 10.3390/jof8090893
By:
- Poirier, Maxime;
- Hugot, Cindy;
- Spatz, Madeleine;
- Da Costa, Gregory;
- Lapiere, Alexia;
- Michaudel, Chloé;
- Danne, Camille;
- Martin, Valérie;
- Langella, Philippe;
- Michel, Marie-Laure;
- Sokol, Harry;
- Boyaval, Patrick;
- Richard, Mathias L.
Publication type:
Article
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023.
Published in:
Current Oncology, 2023, v. 30, n. 9, p. 8172, doi. 10.3390/curroncol30090593
By:
- Al-Mansor, Essa;
- Mahoney, Meghan;
- Chenard-Poirier, Maxime;
- Ramjeesingh, Ravi;
- Nair, Vimoj;
- Kennedy, Erin;
- Locke, Gordon;
- Welch, Stephen;
- Berry, Scott;
- Couture, Felix;
- Elimova, Elena;
- Pollett, Aaron;
- Mahmud, Aamer;
- Wilson, Brooke;
- Armstrong, Dawn;
- Falkson, Conrad;
- Asmis, Timothy;
- Vickers, Michael;
- Goodwin, Rachel
Publication type:
Article
Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions.
Published in:
2018
By:
- Bandet, Cécile L.;
- Mahfouz, Rana;
- Véret, Julien;
- Sotiropoulos, Athanassia;
- Poirier, Maxime;
- Giussani, Paola;
- Campana, Mélanie;
- Philippe, Erwann;
- Blachnio-Zabielska, Agnieszka;
- Ballaire, Raphaëlle;
- Liepvre, Xavier Le;
- Bourron, Olivier;
- Berkeš, Dušan;
- Górski, Jan;
- Ferré, Pascal;
- Stunff, Hervé Le;
- Foufelle, Fabienne;
- Hajduch, Eric;
- Le Liepvre, Xavier;
- Le Stunff, Hervé
Publication type:
journal article

Found: 6

A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumors.

Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer.

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.

Effects of Five Filamentous Fungi Used in Food Processes on In Vitro and In Vivo Gut Inflammation.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2023.

Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions.